Skip to Content

M 138 M 138 (Stavudine 40 mg)

Pill with imprint M 138 M 138 is Orange, Capsule-shape and has been identified as Stavudine 40 mg. It is supplied by Mylan Pharmaceuticals Inc..

Stavudine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Stavudine 40 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for M 138 M 138


M 138 M 138
40 mg
22.00 mm
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
lactose anhydrous
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
D&C Red No. 28
D&C Yellow No. 10
FD&C Yellow No. 6
titanium dioxide
ferrosoferric oxide
potassium hydroxide
propylene glycol
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
54569-6123 A-S Medication Solutions, LLC (repackager)

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.